Loading...
Study on Biopharmaceutics Classification and Oral Bioavailability of a Novel Multikinase Inhibitor NCE for Cancer Therapy
Specific biopharmaceutics classification investigation and study on phamacokinetic profile of a novel drug candidate (2-methylcarbamoyl-4-{4-[3- (trifluoromethyl) benzamido] phenoxy} pyridinium 4-methylbenzenesulfonate monohydrate, NCE) were carried out. Equilibrium solubility and intrinsic dissolut...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Molecular Diversity Preservation International (MDPI)
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4057667/ https://ncbi.nlm.nih.gov/pubmed/24776763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms15057199 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|